GlassScriptPhysician profile
Michael P Defrain
NPI 1851369490
$127,857.55
in general payments reported to CMS, 2019-2025
24 companies · $69K in 2025
The $69K reported for 2025 was more than what 98% of Thoracic Surgery (Cardiothoracic Vascular Surgery) providers received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $633 · 2020: $1,758 · 2021: $525 · 2022: $4,029 · 2023: $1,215 · 2024: $51K · 2025: $69K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $80K · Travel and Lodging: $21K · Food and Beverage: $12K · Consulting Fee: $8,700.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $79,500.00 |
| Travel and Lodging | $20,892.39 |
| Food and Beverage | $11,820.55 |
| Consulting Fee | $8,700.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lsi Solutions INC | $103,493.60 | 2019-2025 | Ram, Cor-Knot, Minirumel |
| Arthrex, INC. | $12,532.44 | 2020-2025 | Shoulder Suture Fiberwire |
| Medtronic, INC. | $4,730.16 | 2021-2025 | Corevalve Evolut R, Avalus, Mosaic |
| Intuitive Surgical, INC. | $1,915.29 | 2020-2022 | |
| Abbott Laboratories | $1,668.18 | 2024-2025 | Triclip |
| W. L. Gore & Associates, INC. | $1,252.03 | 2019-2023 | Gore Tag Thoracic Endoprosthesis, Gore Tag Conformable Thoracic Endoprosthesis |
| Medtronic Vascular, INC. | $495.18 | 2019-2020 | |
| Atricure, INC. | $461.17 | 2022-2025 | Atricure Cryoice Cryoablation System (Cryo2), Atriclip Laa Exclusion System |
| Edwards Lifesciences Corporation | $292.94 | 2020-2024 | Konect Resilia |
| Getinge USA Sales, LLC | $277.02 | 2019-2025 | Vasoview Hemopro 2, Heartstring III Proximal Seal |
| Abiomed | $271.42 | 2022-2025 | Impella |
| Astrazeneca Pharmaceuticals LP | $97.64 | 2019 | |
| Zimmer Biomet Holdings, INC. | $51.44 | 2019 | |
| Cvrx, INC. | $49.50 | 2025 | Barostim Neo System |
| Haemonetics Corporation | $45.16 | 2021-2025 | Haemonetics Cell Saver Elite+ System |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Becton, Dickinson and Company | $41.84 | 2025 | Hemosphere |
| Ethicon US, LLC | $38.58 | 2025 | Evarrest, Dermabond, Vistaseal |
| La Jolla Pharmaceutical Company | $35.21 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $23.27 | 2025 | Lifevest |
| Cardiva Medical, INC. | $21.29 | 2023 | Cardiva Vascade 6/7f Vcs |
| Coastal Medical Technologies LLC | $19.99 | 2024 | |
| Corcym INC | $17.38 | 2025 | Mi Detach - Aortic Cross Clamp - Delivery System Kit |
| Cook Medical LLC | $15.67 | 2019 | |
| Angiodynamics, INC. | $11.15 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Defrain listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.